{"count": 7, "results": [{"_id": "39341387", "pmid": 39341387, "title": "Development of inhaled moxifloxacin-metformin formulation as an alternative for pulmonary tuberculosis treatment.", "journal": "Int J Pharm", "authors": ["Simon A", "Velloso-Junior SO", "Mesquita RD", "Fontao AP", "Costa TEMM", "Honorio TS", "Guimaraes TF", "Sousa EGR", "Viçosa AL", "Sampaio ALF", "do Carmo FA", "Healy AM", "Cabral LM", "Castro RR"], "date": "2024-09-26T00:00:00Z", "doi": "10.1016/j.ijpharm.2024.124740", "meta_date_publication": "2024 Sep 26", "meta_volume": "", "meta_issue": "", "meta_pages": "124740", "score": 50263.3, "text_hl": "Development of inhaled @CHEMICAL_Moxifloxacin @CHEMICAL_MESH:D000077266 @@@moxifloxacin@@@-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ formulation as an alternative for @<m>DISEASE_Tuberculosis_Pulmonary</m> @DISEASE_MESH:D014397 @@@pulmonary tuberculosis@@@ treatment.", "citations": {"NLM": "Simon A, Velloso-Junior SO, Mesquita RD, Fontao AP, Costa TEMM, Honorio TS, Guimaraes TF, Sousa EGR, Viçosa AL, Sampaio ALF, do Carmo FA, Healy AM, Cabral LM, Castro RR. Development of inhaled moxifloxacin-metformin formulation as an alternative for pulmonary tuberculosis treatment. Int J Pharm. 2024 Sep 26;():124740. PMID: 39341387", "BibTeX": "@article{39341387, title={Development of inhaled moxifloxacin-metformin formulation as an alternative for pulmonary tuberculosis treatment.}, author={Simon A and Velloso-Junior SO and Mesquita RD and Fontao AP and Costa TEMM and Honorio TS and Guimaraes TF and Sousa EGR and Viçosa AL and Sampaio ALF and do Carmo FA and Healy AM and Cabral LM and Castro RR}, journal={Int J Pharm}, pages={124740}}"}}, {"_id": "34849651", "pmid": 34849651, "pmcid": "PMC9427151", "title": "Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis", "journal": "Clin Infect Dis", "authors": ["Padmapriydarsini C", "Mamulwar M", "Mohan A", "Shanmugam P", "Gomathy NS", "Mane A", "Singh UB", "Pavankumar N", "Kadam A", "Kumar H", "Suresh C", "Reddy D", "Devi P", "Ramesh PM", "Sekar L", "Jawahar S", "Shandil RK", "Singh M", "Menon J", "Guleria R"], "date": "2022-08-31T00:00:00Z", "doi": "10.1093/cid/ciab964", "meta_date_publication": "2022 Aug 31", "meta_volume": "75", "meta_issue": "3", "meta_pages": "425-434", "score": 50257.9, "text_hl": "Randomized Trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ With Anti-@DISEASE_Tuberculosis @DISEASE_MESH:D014376 @@@Tuberculosis@@@ Drugs for Early Sputum Conversion in Adults With @<m>DISEASE_Tuberculosis_Pulmonary</m> @DISEASE_MESH:D014397 @@@Pulmonary Tuberculosis@@@", "citations": {"NLM": "Padmapriydarsini C, Mamulwar M, Mohan A, Shanmugam P, Gomathy NS, Mane A, Singh UB, Pavankumar N, Kadam A, Kumar H, Suresh C, Reddy D, Devi P, Ramesh PM, Sekar L, Jawahar S, Shandil RK, Singh M, Menon J, Guleria R. Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis Clin Infect Dis. 2022 Aug 31;75(3):425-434. PMID: 34849651", "BibTeX": "@article{34849651, title={Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis}, author={Padmapriydarsini C and Mamulwar M and Mohan A and Shanmugam P and Gomathy NS and Mane A and Singh UB and Pavankumar N and Kadam A and Kumar H and Suresh C and Reddy D and Devi P and Ramesh PM and Sekar L and Jawahar S and Shandil RK and Singh M and Menon J and Guleria R}, journal={Clin Infect Dis}, volume={75}, number={3}, pages={425-434}}"}}, {"_id": "38019456", "pmid": 38019456, "title": "Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary Tuberculosis.", "journal": "Ther Drug Monit", "authors": ["Kumar AKH", "Kadam A", "Karunaianantham R", "Tamizhselvan M", "Padmapriyadarsini C", "Mohan A", "Jeyadeepa B", "Radhakrishnan A", "Singh UB", "Bapat S", "Mane A", "Kumar P", "Mamulwar M", "Bhavani PK", "Haribabu H", "Rath N", "Guleria R", "Khan AM", "Menon J", "METRIF Team"], "date": "2023-11-28T00:00:00Z", "doi": "10.1097/FTD.0000000000001149", "meta_date_publication": "2023 Nov 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50253.617, "text_hl": "METHODS: Nondiabetic adults aged 18-60 years with @<m>DISEASE_Tuberculosis_Pulmonary</m> @DISEASE_MESH:D014397 @@@pulmonary tuberculosis@@@ were randomized to either the standard ATT (ATT group) or ATT plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (METRIF group) groups in a phase IIB clinical trial. ", "citations": {"NLM": "Kumar AKH, Kadam A, Karunaianantham R, Tamizhselvan M, Padmapriyadarsini C, Mohan A, Jeyadeepa B, Radhakrishnan A, Singh UB, Bapat S, Mane A, Kumar P, Mamulwar M, Bhavani PK, Haribabu H, Rath N, Guleria R, Khan AM, Menon J, METRIF Team. Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary Tuberculosis. Ther Drug Monit. 2023 Nov 28;():. PMID: 38019456", "BibTeX": "@article{38019456, title={Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary Tuberculosis.}, author={Kumar AKH and Kadam A and Karunaianantham R and Tamizhselvan M and Padmapriyadarsini C and Mohan A and Jeyadeepa B and Radhakrishnan A and Singh UB and Bapat S and Mane A and Kumar P and Mamulwar M and Bhavani PK and Haribabu H and Rath N and Guleria R and Khan AM and Menon J and METRIF Team}, journal={Ther Drug Monit}}"}}, {"_id": "30089476", "pmid": 30089476, "pmcid": "PMC6083564", "title": "Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar", "journal": "BMC Infect Dis", "authors": ["Al-Shaer MH", "Elewa H", "Alkabab Y", "Nazer LH", "Heysell SK"], "date": "2018-08-08T00:00:00Z", "doi": "10.1186/s12879-018-3309-0", "meta_date_publication": "2018 Aug 8", "meta_volume": "18", "meta_issue": "1", "meta_pages": "384", "score": 50074.133, "text_hl": "@SPECIES_9606 @@@Patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and prescribed FDC showed faster smear conversion during treatment for @<m>DISEASE_Tuberculosis_Pulmonary</m> @DISEASE_MESH:D014397 @@@pulmonary TB@@@ compared to ST which was more pronounced in those with 3+ bacillary load pretreatment and which appeared to be modified by higher dose @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Al-Shaer MH, Elewa H, Alkabab Y, Nazer LH, Heysell SK. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar BMC Infect Dis. 2018 Aug 8;18(1):384. PMID: 30089476", "BibTeX": "@article{30089476, title={Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar}, author={Al-Shaer MH and Elewa H and Alkabab Y and Nazer LH and Heysell SK}, journal={BMC Infect Dis}, volume={18}, number={1}, pages={384}}"}}, {"_id": "29540054", "pmid": 29540054, "pmcid": "PMC6129638", "title": "The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus", "journal": "Korean J Intern Med", "authors": ["Lee YJ", "Han SK", "Park JH", "Lee JK", "Kim DK", "Chung HS", "Heo EY"], "date": "2018-09-01T00:00:00Z", "doi": "10.3904/kjim.2017.249", "meta_date_publication": "2018 Sep", "meta_volume": "33", "meta_issue": "5", "meta_pages": "933-940", "score": 50064.96, "text_hl": "Interestingly, in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Tuberculosis_Pulmonary</m> @DISEASE_MESH:D014397 @@@cavitary pulmonary TB@@@, the culture conversion rate after 2 months in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group was much higher than in the non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (OR, 10.80; 95% CI, 1.22 to 95.63; p = 0.03). ", "citations": {"NLM": "Lee YJ, Han SK, Park JH, Lee JK, Kim DK, Chung HS, Heo EY. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus Korean J Intern Med. 2018 Sep;33(5):933-940. PMID: 29540054", "BibTeX": "@article{29540054, title={The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus}, author={Lee YJ and Han SK and Park JH and Lee JK and Kim DK and Chung HS and Heo EY}, journal={Korean J Intern Med}, volume={33}, number={5}, pages={933-940}}"}}, {"_id": "30205606", "pmid": 30205606, "pmcid": "PMC6162822", "title": "Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients", "journal": "J Clin Med", "authors": ["Tseng CH"], "date": "2018-09-09T00:00:00Z", "doi": "10.3390/jcm7090264", "meta_date_publication": "2018 Sep 9", "meta_volume": "7", "meta_issue": "9", "meta_pages": "", "score": 50048.605, "text_hl": "Table 4 compares the hazard ratios of any @DISEASE_Tuberculosis @DISEASE_MESH:D014376 @@@TB infection@@@ and @<m>DISEASE_Tuberculosis_Pulmonary</m> @DISEASE_MESH:D014397 @@@pulmonary TB infection@@@ between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ irregular users and regular users versus never users. ", "citations": {"NLM": "Tseng CH. Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients J Clin Med. 2018 Sep 9;7(9):. PMID: 30205606", "BibTeX": "@article{30205606, title={Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients}, author={Tseng CH}, journal={J Clin Med}, volume={7}, number={9}}"}}, {"_id": "30826761", "pmid": 30826761, "pmcid": "PMC6429929", "title": "Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial", "journal": "BMJ Open", "authors": ["Padmapriyadarsini C", "Bhavani PK", "Natrajan M", "Ponnuraja C", "Kumar H", "Gomathy SN", "Guleria R", "Jawahar SM", "Singh M", "Balganesh T", "Swaminathan S"], "date": "2019-03-01T00:00:00Z", "doi": "10.1136/bmjopen-2018-024363", "meta_date_publication": "2019 Mar 1", "meta_volume": "9", "meta_issue": "3", "meta_pages": "e024363", "score": 50047.42, "text_hl": "Evaluation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in combination with @CHEMICAL_Rifampin @CHEMICAL_MESH:D012293 @@@rifampicin@@@ containing antituberculosis therapy in @SPECIES_9606 @@@patients@@@ with new, smear-positive @<m>DISEASE_Tuberculosis_Pulmonary</m> @DISEASE_MESH:D014397 @@@pulmonary tuberculosis@@@ (METRIF): study protocol for a randomised clinical trial", "citations": {"NLM": "Padmapriyadarsini C, Bhavani PK, Natrajan M, Ponnuraja C, Kumar H, Gomathy SN, Guleria R, Jawahar SM, Singh M, Balganesh T, Swaminathan S. Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial BMJ Open. 2019 Mar 1;9(3):e024363. PMID: 30826761", "BibTeX": "@article{30826761, title={Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial}, author={Padmapriyadarsini C and Bhavani PK and Natrajan M and Ponnuraja C and Kumar H and Gomathy SN and Guleria R and Jawahar SM and Singh M and Balganesh T and Swaminathan S}, journal={BMJ Open}, volume={9}, number={3}, pages={e024363}}"}}]}